Instrument Inactif

Communiqués Meda AB

Actions

SE0000221723

Produits pharmaceutiques

Cours en clôture Nasdaq Stockholm
- ^SEK	-

20/07/16	Mylan NV : La CE autorise Mylan à racheter Meda sous conditions	RE
15/07/16	Meda : L'UE devrait accepter le rachat de Meda par Mylan-sources	RE

Communiqués

25/08/16	Meda : Bulletin from the Extraordinary General Meeting in Meda AB (publ)	BU
08/08/16	Meda : Delisting of Meda Aktiebolag (publ)	BU
05/08/16	MEDA: Notice to noteholders regarding change of control	BU
02/08/16	Meda : Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting	BU
02/08/16	Meda : Extraordinary General Meeting of Meda Aktiebolag (publ)	BU
21/07/16	MEDA: Interim Report, January-June 2016	BU
15/07/16	Meda : second quarter 2016 report	PU
15/07/16	MEDA: Meda’s Second Quarter 2016 Report	BU
03/05/16	MEDA: Interim Report, January-March 2016	BU
26/04/16	MEDA: Invitation to teleconference for analysts, investors and media	BU
14/04/16	Meda : publ) : AGM bulletin	BU
07/04/16	Meda : Mylan to present at Meda’s Annual General Meeting	PU
24/03/16	Meda : Annual Report is Published	BU
24/03/16	Meda : annual report is published	PU
11/03/16	Meda : Notice of Annual General Meeting in Meda AB (publ)	BU
11/02/16	Meda : Statement by the Board of Directors of Meda in relation to the public offer by Mylan	BU
10/02/16	MEDA : Year-end Report, January-December 2015	BU
04/02/16	MEDA : Invitation to Teleconference for Analysts, Investors and Media	BU
30/12/15	MEDA : Divestment of Manufacturing Unit Euromed in Spain Completed	BU
01/12/15	Meda : Divests Manufacturing Unit Euromed in Spain	BU
16/11/15	Meda : Update on License Agreement between Meda and Valeant	BU
05/11/15	MEDA : Interim Report, January-September 2015	BU
29/10/15	MEDA : Invitation to teleconference for analysts, investors and media	BU
13/10/15	MEDA : Nomination Committee Appointed	BU
28/08/15	Meda : comment on US rumors	BU